References
- de Boer D, Tan LP, Gorter P, van de Wal RM, Kettenes-van den Bosch JJ, de Bruijn EA, Maes RA. (1997). Gas chromatographic/mass spectrometric assay for profiling the enantiomers of 3,4-methylenedioxymethamphetamine and its chiral metabolites using positive chemical ionization ion trap mass spectrometry. J Mass Spectrom 32:1236–1246.
- Borch RF, Bernstein MD, Durst HD. (1971). The cyanohydridoborate anion as a selective reducing agent. J Am Chem Soc 93:2897–2904.
- Coutts RT, Kovach SH. (1977). Metabolism in vitro of N-methylamphetamine with rat liver homogenates. Biochem Pharmacol 26:1043–1049.
- Dumasia MC. (2003). Identification of some N-hydroxylated metabolites of (+/−)-3,4-methylenedioxymethamphetamine in horse urine by gas chromatography-mass spectrometry. Xenobiotica 33:1013–1025.
- Iio R, Iwamuro Y, Chinaka S, Takayama N, Katagi M, Tsuchihashi H. (2008). Studies on analyses of N-hydroxy-MDMA including MDMA. Jpn J Forensic Sci Tech 13(Suppl): 59 (in Japanese).
- Kamata T, Katagi M, Nakanishi K, Zaitsu K, Shima N, Kamata H, Miki A, Tsuchihashi H. (2010). Metabolism and urinary excretion of N-hydroxy-3,4-methylenedioxymethamphetamine, a recently banned narcotic in Japan. Jpn J Forensic Sci Tech 15:15–23 (in Japanese).
- Kikura-Hanajiri R, Miyajima-Tabata A, Sunouchi M, Kawamura M, Goda Y. (2009). Metabolic properties of N-OH-MDMA in rat and human. Ann Toxicol Anal, 21(Suppl 1), P038.
- Kikura-Hanajiri R, Kawamura M, Miyajima A, Sunouchi M, Goda Y. (2010). Determination of a new designer drug, N-hydroxy-3,4-methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography-tandem mass spectrometry. Forensic Sci Int 198:62–69.
- Miller RR, Doss GA, Stearns RA. (2004). Identification of a hydroxylamine glucuronide metabolite of an oral hypoglycemic agent. Drug Metab Dispos 32:178–185.
- Noami M, Igarashi K, Kasuya F, Ohta M, Kanamori-Kataoka M, Seto Y. (2006). Study on the analysis of capsaicin glucuronide in rat urine by liquid chromatography-mass spectrometry after enzymatic hydrolysis. J Health Sci 52:660–665.
- Shima N, Katagi M, Kamata H, Zaitsu K, Kamata T, Nishikawa M, Miki A, Tsuchihashi H, Sakuma T, Nemoto N. (2008). Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats. Xenobiotica 38:314–324.
- Shulgin AT, Shulgin A. (1992). PiHKAL: A chemical love story. Berkeley, United States: Transform press.
- Sugai S, Ikawa H, Okazaki T, Akaboshi S, Ikegami S. (1982). A versatile synthesis of arylacetones from aryl halides and acetylacetonate. Chem Lett 2:597–600.
- Tsujikawa K, Kuwayama K, Miyaguchi H, Kanamori T, Iwata YT, Inoue H. (2009). Degradation of N-hydroxy-3,4-methylenedioxymethamphetamine in aqueous solution and its prevention. Forensic Sci Int 193:106–111.
- Turgeon J, Paré JR, Lalande M, Grech-Bélanger O, Bélanger PM. (1992). Isolation and structural characterization by spectroscopic methods of two glucuronide metabolites of mexiletine after N-oxidation and deamination. Drug Metab Dispos 20:762–769.
- Uchiyama N, Kikura-Hanajiri R, Fukuhara K, Goda Y. (2009). Decomposition mechanism of N-OH-MDMA and N-OH-MDA in alkali solution. Proceedings of the 129th Annual Meeting of the Pharmaceutical Society of Japan. [Online] Available at: http://nenkai.pharm.or.jp/129/pc/ipdfview.asp?i=2112. Accessed on 22 December 2010. (in Japanese).
- Valaer AK, Ravis WR, Clark CR. (1990). Liquid chromatographic properties and aqueous solution stability of N-hydroxy-3,4-methylenedioxyamphetamine. J Chromatogr Sci 28:482–486.
- Yamamoto T, Takano R, Egashira T, Yamanaka Y. (1984). Metabolism of methamphetamine, amphetamine and p-hydroxymethamphetamine by rat-liver microsomal preparations in vitro. Xenobiotica 14:867–875.